GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

enozertinib   Click here for help

GtoPdb Ligand ID: 13744

Synonyms: example 57 [US11466000B2]
Compound class: Synthetic organic
Comment: Enozertinib is the INN for an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that is claimed in Voronoi Inc. patent US11466000B2 (as example 57) [1]. Voronoi have two EGFR inhibitors listed on their development pipeline page (VRN07 and VRN11), but without a name to structure declaration we cannot be sure which one wil be aligned with this INN.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 97.27
Molecular weight 660.76
XLogP 2.07
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CC(=O)NC1=C(C=C(C(=C1)NC2=NC=NC(=C2)N3[C@]([H])(CCO3)C4=CC(=CC(=C4)F)F)OC)N5CCC(CC5)N6CCN(CC6)C7CC7
Isomeric SMILES [H][C@@]1(CCON1C2=CC(NC3=CC(NC(=O)C=C)=C(C=C3OC)N4CCC(CC4)N5CCN(CC5)C6CC6)=NC=N2)C7=CC(F)=CC(F)=C7
InChI InChI=1S/C35H42F2N8O3/c1-3-35(46)41-28-19-29(40-33-21-34(39-22-38-33)45-30(8-15-48-45)23-16-24(36)18-25(37)17-23)32(47-2)20-31(28)44-9-6-27(7-10-44)43-13-11-42(12-14-43)26-4-5-26/h3,16-22,26-27,30H,1,4-15H2,2H3,(H,41,46)(H,38,39,40)/t30-/m1/s1
InChI Key NNDXFTMFJKUUQA-SSEXGKCCSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Lee Y H, Kang JH, Kang SI, Ko YK, Ko EH, Choi HG, Son JB, Kim ND. (2022)
Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component.
Patent number: US11466000B2. Assignee: Voronoi Inc. Priority date: 08/11/2021. Publication date: 11/10/2022.